# FDA Inspection 1141793 - Arevipharma GmbH - September 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/d795ea7c-d802-42db-ae9e-0fbc04a1d9ab
Source feed: FDA_Inspections

> FDA Inspection 1141793 for Arevipharma GmbH on September 16, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141793
- Company Name: Arevipharma GmbH
- Inspection Date: 2019-09-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1288700 - 2025-06-20](https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/c286f0d5-f5e5-4af8-b1d5-56d82a663486)
- [FDA Inspection 1288700 - 2025-06-20](https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/95d2bed1-4246-462e-a5ca-81741f1186d9)
- [FDA Inspection 969875 - 2016-04-29](https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/04a304d7-4967-4430-9d3c-433fdd93dbcd)
- [FDA Inspection 808573 - 2012-11-16](https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/8cf2f1c7-0687-450b-99d5-d080aeaa45f1)
- [FDA Inspection 576014 - 2009-04-08](https://www.keypedia.com/records/fda_inspections/arevipharma-gmbh/80ec2170-0902-4afa-8867-90651824614c)

Company: https://www.keypedia.com/companies/arevipharma-gmbh/d2cf1bd6-f918-449d-83e7-70065b9cb728

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c